Literature DB >> 4116627

The probenecid test in Parkinson's disease.

M B Bowers, M H Van Woert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4116627     DOI： 10.1016/s0140-6736(72)92566-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Relationship of age and mood to monoamine metabolites in cerebrospinal fluid in parkinsonism.

Authors:  A K Granerus; T Magnusson; B E Roos; A Svanborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

3.  The effects of probenecid on cyclic adenosine 3',5'-monophosphate levels in cerebrospinal fluid and on brain phosphodiesterase activity in the rat.

Authors:  R Horstmann; R Hammers; P Clarenbach; H Cramer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.